Inhibition of IgE-Production by Peroxisome Proliferator-Activated Receptor Ligands

Journal of Investigative Dermatology

Volumn 121, Issue 4, 2003, Pages 757-764

  Rühl, Ralph ^b   Dahten, Anja ^a,b   Schweigert, Florian J ^b   Herz, Udo ^c   Worm, Margitta ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Atopic dermatitis; Cytokines; IgE; Peroxisome proliferator activated receptor ligands

Indexed keywords

CIGLITAZONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 4; LIGAND; OVALBUMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0141922040     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12493.x     Document Type: Article

References (25)

1. Brown PJ, Winegar DA, Plunket KD, et al: A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity. J Med Chem 42:3785-3788, 1999
2. Chinetti G, Griglio S, Antonucci M, et al: Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273:25573-25580, 1998
3. Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ: The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J Immunol 1:1364-1371, 2000
4. Cunard R, Ricote M, DiCampli D, Archer DC, Kahn DA, Glass CK, Kelly CJ: Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol 168:2795-2802, 2002
5. Ellis CN, Varani J, Fisher GJ, et al: Troglitazone improves psoriasis and normalizes models of proliferative skin disease: Ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation. Arch Dermatol 136:609-616, 2000
6. Frotscher B, Anton K, Worm M: Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors. J Invest Dermatol 119: 1059-1064, 2002
7. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Dermatol Venerol Suppl 92:44-49, 1980
8. Heine G, Anton K, Henz BM, Worm M: 1,25-Dihydroxyvitamin D3 inhibits anti-CD40 + IL-4 mediated IgE production in vitro. Eur J Immunol 32:3395-3404, 2002
9. Herz U, Braun A, Ruckert R, Renz H: Various immunological phenotypes are associated with increased airway responsiveness. Clin Exp Allergy 28:625-634, 1998
10. Huang JT, Welch JS, Ricote M, et al: Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 400:378-382, 1999
11. Kitamura Y, Taniguchi T, Kimura H, Nomura Y, Gebicke-Haerter PJ: Interleukin-4-inhibited mRNA expression in mixed rat glial and in isolated microglial cultures. J Neuroimmunol 106:95-104, 2000
12. Kliewer SA, Xu HE, Lambert MH, Willson TM: Peroxisome proliferator-activated receptors: From genes to physiology. Recent Prog Horm Res 56:239-263, 2001
13. Kubota N, Terauchi Y, Miki H, et al: PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597-609, 2000
14. Lemberger T, Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 12:335-363, 1996
15. Miyazaki Y, Tachibana H, Yamada K: Inhibitory effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of IgE heavy chain germ-line transcripts in the human B cell line DND39. Biochem Biophy Res Commun 295:547-552, 2002
16. Niino M, Iwabuchi K, Kikuchi S, et al: Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma. J Neuroimmunol 116:40-48, 2001
17. Padilla J, Leung E, Phipps RP: Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. Clin Immunol 103: 22-33, 2002
18. Ricote M, Li AC, Willson TM, Kelly CJ. Glass C: PPARgamma is a negative regulator of macrophage activation. Nature 391:79-82, 1998
19. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG: Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 4037:103-108, 2000
20. Setoguchi K, Misaki Y, Terauchi Y, Yamauchi T, Kawahata K, Kadowaki T, Yamamoto K: Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis. J Clin Invest 108:1667-1675, 2001
21. Straus DS, Pascual G, Li M, et al: 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA 97:4844-4849, 2000
22. Su CG, Wen X, Bailey ST, et al: A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 104: 383-389, 2000
23. Vercelli D, Jabara HH, Arai K, Yokota T, Geha RS: Endogenous interleukin 6 plays an obligatory role in interleukin 4-dependent human IgE synthesis. Eur J Immunol 19:1419-1424, 1989
24. Wahli W: Peroxisome Proliferator-Activated Receptors (PPAR): From metabolic control to epidermal wound healing. Swiss Med Wkly 132:83-91, 2002
25. Worm M, Herz U, Krah JM, Renz H, Henz BM: Effects of retinoids on in vitro and in vivo IgE production. Int Arch Allergy Immunol 124:233-236, 2001